Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Onconova Therapeutics Inc (NASDAQ:ONTX)

1.95
Delayed Data
As of Aug 04
 -0.01 / -0.51%
Today’s Change
1.95
Today|||52-Week Range
5.78
-40.73%
Year-to-Date

Today’s Trading

Previous close1.96
Today’s open1.97
Day’s range1.95 - 2.02
Volume10,639
Average volume (3 months)32,375
Market cap$42.3M
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)+51.96%
Earnings growth (this year)+29.59%
Earnings growth (next 5 years)--
Revenue growth (last year)-83.17%
P/E ratioNM
Price/Sales89.05
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc-0.08-2.11%
HEBHemispherx Biopharma...-0.01-2.69%
EYEGEyeGate Pharmaceutic...-0.19-2.84%
GNVCGenVec Inc-0.03-1.23%
Data as of 08/04/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$800.0K
Annual profit (last year)-$63.7M
Net profit margin-7,960.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramesh Kumar
Chief Financial Officer &
Secretary
Ajay Bansal
Corporate headquarters
Newtown, Pennsylvania

Forecasts